Crinetics Pharmaceuticals, Inc. - Common Stock — 현금 흐름 (NASDAQ:CRNX)

Financials

영업활동으로 인한 현금 -62.03 M-88.59 M-115.2 M-166.31 M-225.97 M-377.92 M -414.17 M 투자 활동으로 인한 현금 217 K-56.48 M-173.98 M-200.41 M-574.82 M173.91 M 7.51 M 재무활동으로 인한 현금 114.57 M252.68 M121.96 M388.94 M1.01 B40.61 M 426.05 M 잉여 현금 흐름 -62.03 M-88.59 M-115.2 M-166.31 M-225.97 M-383.68 M -419.52 M

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

CRNX

Financials

Crinetics Pharmaceuticals, Inc. - Common Stock

뉴스

3 Best Healthcare Stocks to Buy in May 2026, According to Analysts - TipRanks.com

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call Transcript

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates

Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)

크리네틱스 파마 이사, 18만 달러 상당 주식 매도

Crinetics Pharma director Vivaldi Coelho sells $180k in stock

크리네틱스 파마 CFO, 26만 6천 달러 상당의 주식 매도

Crinetics Pharma CFO Schilke sells $266k in stock

크리니틱스, Citizens 목표 주가 하향 조정: 밸류에이션 재검토